Searched for
VACCINE EFFICACY DATA
From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...- Leverage the vaccine rollout to mine dataIndia needs to leverage its massive vaccine rollout to use the data it throws up to develop newer and better options. It needs to be forthc...
- Bharat Biotech releases Phase 3 trial data for Covaxin, claims 77.8% efficacyThe trial data also indicated that the vaccine was effective against the Delta variant of the virus
- Sputnik V records 97.8% efficacy against COVID-19 in UAE, fully effective against severe casesIn a statement, the RDIF said that UAE's Ministry of Health confirmed the safety and high efficacy during the vaccination campaign. "Effica...
- Covaxin phase 3 full trial data to be made public in July: Bharat BiotechThe indigenous whole virion inactivated SARS-Cov-2 virus vaccine company has also said that Covaxin will even undergo the phase 4 trials to...
- WHO vaccine experts say Chinese jabs show 'safety', but data lackingThe vaccines demonstrated safety and good efficacy against symptomatic Covid-19 disease but both vaccines lacked data in older age groups a...
- SEC to take up Dr Reddy's application seeking approval to market Sputnik V vaccine“The committee has asked the company to come back with immunogenicity data. Now that they have approached again with the data, the SEC is l...
- Panel to soon take up application for emergency use of Sputnik V in India“The committee had asked the company to come back with immunogenicity data. Now that they have approached again with the data, the SEC is l...
- US health agency questions robustness of AstraZeneca's COVID-19 vaccine trial dataThe Data and Safety Monitoring Board has notified the drugmaker, NIAID and the Biomedical Advanced Research and Development Authority regar...
- Coronavirus vaccine efficacy: What does it mean?Pfizer-Biontech and Moderna recently announced the first interim efficacy analysis of their Covid-19 vaccines. The financial markets cheere...
- Growing uncertainty over efficacy of China made SinovacThe Sinovac allegedly has shown four different efficacy rates during clinical trials ranging from over 91 to 50 per cent. The global scient...
- Explainer: What's behind varying efficacy data for Sinovac's coronavirus vaccine?Researchers in Brazil said it was 50.4% effective at preventing symptomatic infections, barely enough for regulatory approval and below the...
- How SEC changed Covaxin stanceAt the Jan 2 meeting, the firm presented more data and notably “requested for consideration of their proposal in the wake of incidence of n...
- Single Covid-19 vaccine dose or double? Data put regulators in a fixThe US Food and Drug Administration has released its findings on the Pfizer/BioNtech efficacy data where it suggested that the vaccine at a...
- COVID-19: Moderna submits vaccine data to obtain emergency use authorisation"Moderna's data for the emergency use authorisation request for mRNA-1273 has been submitted to the US FDA," Moderna tweeted on Monday.
- The curious case of AstraZeneca-Oxford vaccineThe company announced that in a small subgroup of the trial participants the vaccine showed better efficacy when administered a half dose f...
- After varied efficacy data, AstraZeneca to conduct fresh clinical trials of COVID-19 vaccineAstraZeneca/Oxford said this week it would assess why its vaccine candidate generated better efficacy at a lower dose. The statement came a...
- 3 Covid vaccines’ efficacy higher than flu shotsAnthony Fauci, top infectious disease expert in the US, had said the over 90% efficacy of Pfizer vaccine candidate ‘is just extraordinary’ ...
- AstraZeneca/Oxford say Covid vaccine shows 70% efficacy, can be 90% effective"This vaccine's efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this pub...
- India in dialogue with Moderna, other biotech firms over progress in COVID vaccine development: SourcesModerna on Monday said the independent National Institutes of Health-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of...
Load More
